Le Lézard
Classified in: Covid-19 virus
Subject: Product/Service

NYC Test & Trace Corps Partners With Acuity International to Expand Testing Access


Through the partnership of Acuity International and NYC Health + Hospitals, more than 500 healthcare professionals have been deployed to stand up 60 COVID-19 testing sites in locations across all five boroughs of New York City. Each site is testing an average of 400 people a day.

Acuity International is a leading provider of process and technology-based critical services to global government and commercial enterprises. NYC Health + Hospitals is the nation's largest public hospital system. NYC Test & Trace Corps is an interagency effort led by NYC Health + Hospitals and NYC Department of Health and Mental Hygiene to ensure New Yorkers have no-charge, no-barrier testing access. The partnership was formed to surge COVID-19 testing teams across New York City in direct response to the Omicron wave.

During New York City's efforts to rapidly respond to the global COVID-19 pandemic, Acuity and NYC Health + Hospitals have worked side-by-side to provide emergency healthcare support to New Yorkers. "The working relationship and great esprit de corps that we have built together over the last year and a half have enabled our two organizations to effectively deliver excellent health support during this historic and challenging time," said James Hill, Acuity project manager.

"Acuity has deep expertise supporting large, complex projects that need to be deployed quickly and is proud to bring this expertise to bear in New York City again as it works to give access to testing to all of its citizens," said David Franco, Acuity assistant project manager. This is Acuity's fourth support mission in New York. In early 2020 during the COVID-19 pandemic outbreak, Acuity deployed 500 medical personnel and established within a week a temporary 450-bed medical facility on the grounds of the U.S. Tennis Open at the Billie Jean King National Tennis Center in Queens.

"Our growing relationship with NYC Health + Hospitals is a testament to our ability to be agile and draw on our significant logistics expertise, information technology prowess, and medical know-how as we've helped them meet the challenges of a dynamic pandemic that has required a nimble response," added Megan Riedy, Acuity's chief nurse on this project. "We are also drawing on the operational know-how and solid relationships in each of the boroughs that we have developed over the last 24 months."

COVID-19 testing is offered as a walk-in service with no appointment needed. Sites open daily at 9 AM. NYC Health + Hospitals has a COVID Hotline, 1-212-COVID19, and a full list of testing sites is available online at: https://www.nychealthandhospitals.org/covid-19-testing-sites/.

About Acuity International

Acuity International, headquartered in Reston, Virginia, provides process and technology-based critical services to global government and commercial enterprises. With expertise in a range of engineering and consulting, software solutions, medical care, occupational health, global mission, environmental remediation, and secure and complex construction management services, augmented by deep expertise in cybersecurity, artificial intelligence, and cloud solutions, Acuity International is positioned to assist its customers in their critical missions anywhere in the world with the latest technology and repeatable processes. For more information, visit: https://acuityinternational.com.


These press releases may also interest you

18 mai 2024
Emmy-winning actor and St. Louis native Jon Hamm took the stage Saturday, May 18, to offer words of wisdom to the newest graduates of Saint Louis University (SLU) during the University's spring commencement in St. Louis. ...

18 mai 2024
Nearly 900 undergraduates of the Class of 2024 celebrated their send-off from Bentley University in a very different way than their 2020 arrival amid the COVID-19 pandemic. The 105th undergraduate commencement ceremony was marked by maskless smiles,...

18 mai 2024
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...

18 mai 2024
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...

17 mai 2024
Federal, provincial and territorial (FPT) ministers responsible for culture and heritage held their annual meeting in Whitehorse, Yukon, on May 15?17, 2024, to discuss priority topics, share information and exchange best practices on current issues...

17 mai 2024
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of QuidelOrtho Corporation between February 18, 2022 and April 1, 2024, both dates inclusive (the "Class Period") of the important June 11, 2024 lead...



News published on and distributed by: